(R)-WAC-224

N/A

Report date: 2024/11/06 09:32:36
NME

Base Information

Drug Name(R)-WAC-224
Drug Alias Name(R)-WAC-224R-WACracemic WAC-224WAC-224R-WAC-224
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHiroshima University
China Registration ClassN/A

Develop Information

Active CompaniesHiroshima University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A